Literature DB >> 28823575

High-grade neuroendocrine carcinoma of the urachus-report of 3 cases.

Gang Wang1, He Huang1, Ashish M Kamat2, Arlene Siefker-Radtke3, Colin P Dinney2, Patricia Troncoso1, Bogdan Czerniak1, Charles C Guo4.   

Abstract

Most urachal malignancies are composed of pure adenocarcinoma with mucin production. Urachal neuroendocrine carcinoma (NEC) is extremely rare, with only a few cases reported in the literature. Here we report 3 cases of urachal NEC, the largest series of this rare disease from a single institution. The patients were young, with a mean age of 27 years (range, 23-34). The urachal tumors showed 2 distinct components: high-grade NEC and enteric-type adenocarcinoma. The urachal NECs were composed of small cell carcinoma (n=2) or large cell NEC (n=1). The subsequent resection specimens showed that all the tumors were at advanced Sheldon stages. All 3 patients developed metastases, which were composed of NEC exclusively. Two patients died from disease in 10 and 31 months, respectively, and the third patient was alive with widespread metastases at 21 months. Our findings suggest that urachal NEC is an aggressive variant with an overwhelming growth advantage over conventional adenocarcinoma. The presence of high-grade NEC in the urachus is associated with poor prognosis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Large cell neuroendocrine carcinoma; Neuroendocrine differentiation; Small cell carcinoma; Urachal neuroendocrine carcinoma; Urachal nonglandular carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28823575     DOI: 10.1016/j.humpath.2017.08.003

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  2 in total

1.  Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal Carcinoma.

Authors:  Michael P Zaleski; Hui Chen; Sinchita Roy-Chowdhuri; Keyur P Patel; Rajyalakshmi Luthra; Mark J Routbort; Ashish M Kamat; Jianjun Gao; Arlene Siefker-Radtke; Bogdan Czerniak; Charles C Guo
Journal:  Am J Clin Pathol       Date:  2022-08-04       Impact factor: 5.400

2.  A Case of Bladder Large Cell Carcinoma with Review of the Literature.

Authors:  Paolo Lopedote; Amir Yosef; Olga Kozyreva
Journal:  Case Rep Oncol       Date:  2022-03-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.